Herborium Group Analysis

HBRMDelisted Stock  USD 0.0001  0.00  0.00%   
Herborium Group is overvalued with Real Value of 9.5E-5 and Hype Value of 1.25E-4. The main objective of Herborium pink sheet analysis is to determine its intrinsic value, which is an estimate of what Herborium Group is worth, separate from its market price. There are two main types of Herborium's stock analysis: fundamental analysis and technical analysis.
The Herborium pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Herborium Pink Sheet Analysis Notes

The company had not issued any dividends in recent years. Herborium Group had 1:1000 split on the 27th of January 2014. Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey. Herborium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2 people.The quote for Herborium Group is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Herborium Group call Agnes Olszewski at 201-849-4431 or check out https://www.herborium.com.

Herborium Group Investment Alerts

Herborium Group is not yet fully synchronised with the market data
Herborium Group has some characteristics of a very speculative penny stock
Herborium Group has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 908.6 K. Net Loss for the year was (32.2 K) with profit before overhead, payroll, taxes, and interest of 125.4 K.

Herborium Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 220.29 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Herborium's market, we take the total number of its shares issued and multiply it by Herborium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Herborium Profitablity

The company has Profit Margin (PM) of 0.26 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.98) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.98.

Herborium Outstanding Bonds

Herborium issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Herborium Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Herborium bonds can be classified according to their maturity, which is the date when Herborium Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Herborium Predictive Daily Indicators

Herborium intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Herborium pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Herborium Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Herborium prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Herborium shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Herborium. By using and applying Herborium Pink Sheet analysis, traders can create a robust methodology for identifying Herborium entry and exit points for their positions.
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey. Herborium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Herborium to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Herborium Pink Sheet

If you are still planning to invest in Herborium Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Herborium's history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets